# Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis

> **NCT00109681** · PHASE2 · COMPLETED · sponsor: **Actelion** · enrollment: 50 (—)

## Conditions studied

- Pulmonary Fibrosis
- Pulmonary Hypertension

## Interventions

- **DRUG:** Iloprost Inhalation Solution (Ventavis)

## Key facts

- **NCT ID:** NCT00109681
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 50 (—)
- **Last updated:** 2010-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109681, "Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00109681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*